The Economic Case for Health Equity Investment: Why Closing the Gap Costs Less Than Maintaining It

Health inequity is routinely framed as a moral and social justice issue. It is also an economic one. The United States spends an estimated $320 billion annually on excess medical costs attributable to health disparities — costs borne by health systems, employers, insurers, and public budgets. This brief presents the economic case for health equity investment, drawing on national research and DaisyMe Foundation's program data to quantify the financial burden of the status quo and the return on investment from community-based health equity programs. We argue that health equity investment is not charity — it is cost reduction, risk mitigation, and workforce optimization. And we present DaisyMe Foundation's community health programs as a documented, measurable model for achieving that return.

The Economic Case for Health Equity Investment: Why Closing the Gap Costs Less Than Maintaining It

DaisyMe Foundation Policy Brief DMF-2026-003 Published July 2026 · Frisco, TX

Abstract

Health inequity is routinely framed as a moral and social justice issue. It is also an economic one. The United States spends an estimated $320 billion annually on excess medical costs attributable to health disparities — costs borne by health systems, employers, insurers, and public budgets. This brief presents the economic case for health equity investment, drawing on national research and DaisyMe Foundation's program data to quantify the financial burden of the status quo and the return on investment from community-based health equity programs. We argue that health equity investment is not charity — it is cost reduction, risk mitigation, and workforce optimization. And we present DaisyMe Foundation's community health programs as a documented, measurable model for achieving that return.

1. The Cost of the Status Quo

1.1 The National Burden

The economic burden of health disparities in the United States is substantial and well-documented. A 2023 analysis by the Deloitte Center for Health Solutions estimated that health inequities cost the U.S. economy $320 billion annually in excess medical spending — a figure projected to reach $1 trillion by 2040 if current trends continue.

The components of that burden include:

Uncompensated care: U.S. hospitals provide approximately $42 billion in uncompensated care annually. Uninsured and underinsured patients — who are disproportionately from underrepresented populations — are more likely to delay care until conditions become acute, resulting in emergency department visits and hospitalizations that are significantly more expensive than the preventive care that would have avoided them.

Avoidable hospitalizations: The Agency for Healthcare Research and Quality estimates that $33 billion in annual hospitalizations are potentially preventable through appropriate primary and preventive care. Rates of preventable hospitalization are significantly higher for Black, Hispanic, and low-income populations — populations that face the greatest barriers to primary care access.

Chronic disease burden: Chronic diseases — diabetes, hypertension, cardiovascular disease, asthma — account for 90% of U.S. healthcare spending. These conditions are significantly more prevalent in underrepresented populations, and they are significantly more expensive to manage when they are diagnosed late, managed inconsistently, or complicated by inadequate follow-up care.

1.2 The Employer Burden

Health inequity is not only a healthcare system problem. It is an employer problem.

Research from the Robert Wood Johnson Foundation estimates that health disparities cost U.S. employers $35 billion annually in lost productivity — through absenteeism, presenteeism (working while sick), and premature workforce exit due to preventable chronic disease.

The workforce implications are particularly acute for employers in regions with large underrepresented populations. In the Dallas–Fort Worth Metroplex — where DaisyMe Foundation operates — Black and Hispanic workers represent a significant and growing share of the workforce. Employers who do not invest in the health equity of their workforce are absorbing the productivity costs of that inequity in their bottom line.

1.3 The Public Budget Burden

Medicaid, the primary payer for low-income and underrepresented populations, spent approximately $805 billion in federal and state funds in fiscal year 2024. A significant portion of that spending is attributable to conditions that could have been prevented or managed more cost-effectively with earlier intervention.

The Congressional Budget Office has estimated that every dollar invested in community health workers and navigation programs generates $2.47 to $3.80 in reduced Medicaid spending through averted hospitalizations, reduced emergency department utilization, and improved chronic disease management.

2. The Return on Community Health Investment

2.1 Navigation as Cost Avoidance

DaisyMe Foundation's care navigation programs connect community members to primary care, enroll uninsured participants in coverage, and support chronic disease management. The economic value of these interventions is measurable.

Among the 4,200+ individuals connected to primary care through DaisyMe's navigation programs:

• 1,800+ uninsured participants were enrolled in coverage — reducing their likelihood of emergency department utilization as a primary care substitute
• 79% maintained follow-up care compliance at 90 days — a rate significantly higher than the national average for newly enrolled Medicaid beneficiaries
• Average time to first appointment: under 7 days — compared to a national average of 24 days for uninsured patients, reducing the likelihood of condition escalation during the wait

The cost of an emergency department visit for a condition that could have been managed in primary care averages $2,032 (AHRQ, 2023). The cost of a primary care visit averages $250. Navigation programs that redirect even a fraction of avoidable emergency department visits to primary care generate substantial cost savings for health systems and payers.

2.2 Health Literacy as Chronic Disease Management

DaisyMe's health literacy programs — covering diabetes prevention, hypertension management, maternal health, and mental wellness — produce measurable improvements in health behavior and self-management capacity.

Among participants who completed DaisyMe's health literacy workshops:

• 83% completed chronic disease self-management modules
• 91% reported increased confidence in their ability to make care decisions
• 87% reported improved health access at 6-month follow-up

The economic value of improved chronic disease self-management is well-established. A 2022 analysis in Health Affairs found that community-based diabetes prevention programs generate an average return of $2.65 per dollar invested through reduced hospitalizations, reduced medication costs, and improved workforce productivity.

2.3 Clinical Research Inclusion as Pipeline Value

DaisyMe's clinical research inclusion program has enrolled 2,100+ underrepresented participants in clinical trials through 14 partner research institutions. The economic value of this contribution to the research pipeline is significant.

Clinical trial sponsors spend an average of $6,533 per enrolled participant on recruitment and retention. Community-based recruitment through trusted organizations like DaisyMe significantly reduces that cost while improving the demographic representativeness of trial populations — a regulatory and commercial imperative as FDA guidance increasingly emphasizes diverse trial enrollment.

3. The Investment Framework

3.1 For Health Systems

Health systems that partner with DaisyMe Foundation gain access to:

• Navigation infrastructure that reduces avoidable emergency department utilization and improves follow-up care compliance
• Community trust that enables engagement with populations who currently avoid care — reducing the uncompensated care burden from delayed-presentation acute conditions
• Real-world equity data that supports Section 1557 compliance documentation and quality improvement initiatives

The return on this investment is measurable in reduced uncompensated care, reduced avoidable hospitalization rates, and improved chronic disease management outcomes for the populations DaisyMe serves.

3.2 For Employers

Employers in the Dallas–Fort Worth Metroplex and beyond who partner with DaisyMe Foundation gain access to:

• Workforce health programs that address the chronic disease burden driving absenteeism and presenteeism
• Health literacy education that improves employees' ability to navigate the healthcare system and manage their own health
• Community health navigation that connects employees and their families to appropriate care before conditions become acute

The return on this investment is measurable in reduced absenteeism, reduced short-term disability claims, and improved workforce retention.

3.3 For Funders and Philanthropists

Foundations and individual donors who invest in DaisyMe Foundation's programs are funding a model with a documented return:

• 12,400+ community members served since 2022
• 87% reporting improved health access at follow-up
• 2,100+ underrepresented participants enrolled in clinical research
• 48 institutional partners across health systems, nonprofits, and municipalities

Every dollar invested in DaisyMe's programs funds direct service delivery, community health research, and systemic advocacy — three mutually reinforcing activities that compound over time as the evidence base grows and the community trust deepens.

4. The Cost of Inaction

The economic case for health equity investment is not only about the return on investment. It is also about the cost of inaction.

Health systems that do not address the equity gaps in their clinical AI systems face growing Section 1557 liability exposure as HHS OCR enforcement activity increases. Employers who do not invest in the health equity of their workforce will continue to absorb the productivity costs of preventable chronic disease. Policymakers who do not fund community-based health equity programs will continue to pay for the avoidable hospitalizations and emergency department visits that result from inadequate primary care access.

The question is not whether to pay for health inequity. It is whether to pay for it on the front end — through prevention, navigation, and education — or on the back end — through emergency care, avoidable hospitalization, and lost productivity.

The evidence is clear: the front end is cheaper.

5. Recommendations

For Health System Leadership

1. Budget for community health navigation as a cost reduction strategy, not as a community benefit obligation. The return on navigation investment is measurable and should be tracked as a quality improvement metric.

2. Partner with community health organizations for real-world equity monitoring. The cost of a Section 1557 enforcement action significantly exceeds the cost of the community partnership that would have identified the equity gap before it became a liability.

3. Include community-sourced data in clinical AI procurement requirements. Require vendors to provide disaggregated equity validation data before deployment.

For Employers

1. Treat workforce health equity as a business continuity issue. The productivity costs of preventable chronic disease are a material business risk, not a social responsibility line item.

2. Partner with community health organizations to extend health literacy programming to employees and their families. The return on health literacy investment compounds over time as employees become more effective self-advocates and chronic disease managers.

For Policymakers

1. Fund community health organizations as economic infrastructure. The CBO's estimated $2.47–$3.80 return on every dollar invested in community health workers should inform appropriations decisions at the federal and state level.

2. Require health equity impact assessments for major health policy changes. Medicaid cuts, coverage restrictions, and benefit changes should be evaluated for their economic impact on the communities most affected — including the downstream costs to health systems, employers, and public budgets.

6. Conclusion

The moral case for health equity is clear and does not require an economic argument. But the economic case is also clear — and for the decision-makers who control the resources required to close the equity gap, it may be the more persuasive one.

Health inequity costs the United States $320 billion annually. Community-based health equity programs generate documented returns of $2.47 to $3.80 per dollar invested. The math is not complicated.

DaisyMe Foundation is committed to making that case — with data, with evidence, and with the 12,400+ community members whose health outcomes are the proof of concept.

About DaisyMe Foundation

DaisyMe Foundation is a 501(c)(3) nonprofit organization headquartered in Frisco, Texas. We advance health equity for underrepresented communities through direct service programs, community health research, and systemic advocacy. Since 2022, we have served 12,400+ community members across the Dallas–Fort Worth Metroplex, Houston, and San Antonio.

Contact: info@daisyme.org · daisyme.org

© 2026 DaisyMe Foundation. This brief may be reproduced for educational and advocacy purposes with attribution. Citations: Deloitte Center for Health Solutions, 2023; AHRQ National Healthcare Quality and Disparities Report, 2023; Robert Wood Johnson Foundation, 2022; Congressional Budget Office, Community Health Worker ROI Analysis, 2022; Health Affairs, Diabetes Prevention Program Economic Analysis, 2022.